Scientific Literature Search

Open access

Nigrostriatal dynein changes in A53T alpha-synuclein transgenic mice.

Liu Y, Yuan YH, Sun JD, Li J, Li ZP, Chen NH.

F1000Res · 2014-03-11

DOI: 10.12688/f1000research.3507.1PMID: 25210616

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

Stewart T, Liu C, Ginghina C, Cain KC, Auinger P, Cholerton B, Shi M, Zhang J, Parkinson Study Group DATATOP Investigators.

Am J Pathol · 2014-03-11

DOI: 10.1016/j.ajpath.2013.12.007PMID: 24625392

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.

Diepenbroek M, Casadei N, Esmer H, Saido TC, Takano J, Kahle PJ, Nixon RA, Rao MV, Melki R, Pieri L, Helling S, Marcus K, Krueger R, Masliah E, Riess O, Nuber S.

Hum Mol Genet · 2014-03-11

DOI: 10.1093/hmg/ddu112PMID: 24619358

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Does uncoupling protein 2 expression qualify as marker of disease status in LRRK2-associated Parkinson's disease?

Grünewald A, Arns B, Meier B, Brockmann K, Tadic V, Klein C.

Antioxid Redox Signal · 2014-03-07

DOI: 10.1089/ars.2013.5737PMID: 24251413

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.

Kong SM, Chan BK, Park JS, Hill KJ, Aitken JB, Cottle L, Farghaian H, Cole AR, Lay PA, Sue CM, Cooper AA.

Hum Mol Genet · 2014-03-06

DOI: 10.1093/hmg/ddu099PMID: 24603074

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

δ-Opioid receptor activation reduces α-synuclein overexpression and oligomer formation induced by MPP(+) and/or hypoxia.

Chen T, Li J, Chao D, Sandhu HK, Liao X, Zhao J, Wen G, Xia Y.

Exp Neurol · 2014-03-05

DOI: 10.1016/j.expneurol.2014.02.022PMID: 24613828

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Markopoulou K, Biernacka JM, Armasu SM, Anderson KJ, Ahlskog JE, Chase BA, Chung SJ, Cunningham JM, Farrer M, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord · 2014-03-05

DOI: 10.1016/j.parkreldis.2014.02.021PMID: 24656894

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease.

Shannon B, Soto-Ortolaza A, Rayaprolu S, Cannon HD, Labbé C, Benitez BA, Choi J, Lynch T, Boczarska-Jedynak M, Opala G, Krygowska-Wajs A, Barcikowska M, Van Gerpen JA, Uitti RJ, Springer W, Cruchaga C, Wszolek ZK, Ross OA.

Neurobiol Aging · 2014-03-05

DOI: 10.1016/j.neurobiolaging.2014.03.004PMID: 24684791

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity.

Liu HF, Lu S, Ho PW, Tse HM, Pang SY, Kung MH, Ho JW, Ramsden DB, Zhou ZJ, Ho SL.

Ann Clin Transl Neurol · 2014-03-04

DOI: 10.1002/acn3.45PMID: 25356398

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.

May VE, Ettle B, Poehler AM, Nuber S, Ubhi K, Rockenstein E, Winner B, Wegner M, Masliah E, Winkler J.

Neurobiol Aging · 2014-03-04

DOI: 10.1016/j.neurobiolaging.2014.02.028PMID: 24698767

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway.

Wilding C, Bell K, Beck S, Funke S, Pfeiffer N, Grus FH.

PLoS One · 2014-03-03

DOI: 10.1371/journal.pone.0090737PMID: 24595072

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain.

Liao J, Wu CX, Burlak C, Zhang S, Sahm H, Wang M, Zhang ZY, Vogel KW, Federici M, Riddle SM, Nichols RJ, Liu D, Cookson MR, Stone TA, Hoang QQ.

Proc Natl Acad Sci U S A · 2014-03-03

DOI: 10.1073/pnas.1323285111PMID: 24591621

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

15.468 articles found

Nigrostriatal dynein changes in A53T alpha-synuclein transgenic mice.

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.

Does uncoupling protein 2 expression qualify as marker of disease status in LRRK2-associated Parkinson's disease?

Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.

δ-Opioid receptor activation reduces α-synuclein overexpression and oligomer formation induced by MPP(+) and/or hypoxia.

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease.

LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity.

α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.

γ-Synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway.

Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain.

Filters